Literature DB >> 15458276

Effects of n-3 fatty acids on serum interleukin-6, tumour necrosis factor-alpha and soluble tumour necrosis factor receptor p55 in active rheumatoid arthritis.

T Sundrarjun1, S Komindr, N Archararit, W Dahlan, O Puchaiwatananon, S Angthararak, U Udomsuppayakul, S Chuncharunee.   

Abstract

We investigated the effects of a low n-6 fatty acid (FA) diet supplemented with fish oil on serum pro-inflammatory cytokine concentrations and clinical variables in patients with active rheumatoid arthritis (RA). Sixty patients were randomly assigned to receive a diet low in n-6 FAs and n-3 FAs supplement (fish oil group), a diet low in n-6 FAs and placebo (placebo group), or no special diet or intervention (control group). Serum cytokines and clinical and biochemical variables were evaluated at baseline and various timepoints. At week 18 the fish oil group had significant reductions in linoleic acid, C-reactive protein (CRP) and soluble tumour necrosis factor receptor p55 (sTNF-R p55), and significant elevations in eicosapentaenoic acid and docosahexaenoic acid compared with baseline. There were no significant differences in the clinical variables between the three groups. At week 24 there were significant reductions in interleukin-6 and TNF-alpha in the fish oil and placebo groups. Supplementation with n-3 FA and a low n-6 FA intake decreased serum sTNF-R p55 and CRP levels in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15458276     DOI: 10.1177/147323000403200501

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  21 in total

Review 1.  Polyunsaturated fatty acids and peripheral artery disease.

Authors:  S Marlene Grenon; Millie Hughes-Fulford; Joseph Rapp; Michael S Conte
Journal:  Vasc Med       Date:  2012-02       Impact factor: 3.239

2.  n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.

Authors:  S Marlene Grenon; Christopher D Owens; Hugh Alley; Karen Chong; Priscilla K Yen; William Harris; Millie Hughes-Fulford; Michael S Conte
Journal:  Vasc Med       Date:  2013-09-19       Impact factor: 3.239

Review 3.  Pathogenesis of degenerative temporomandibular joint arthritides.

Authors:  Stephen B Milam
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

4.  Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927.

Authors:  Dawn L Hershman; Joseph M Unger; Katherine D Crew; Danielle Awad; Shaker R Dakhil; Julie Gralow; Heather Greenlee; Danika L Lew; Lori M Minasian; Cathee Till; James L Wade; Frank L Meyskens; Carol M Moinpour
Journal:  J Clin Oncol       Date:  2015-05-04       Impact factor: 44.544

5.  Plasma polyunsaturated fatty acids and the decline of renal function.

Authors:  Fulvio Lauretani; Richard D Semba; Stefania Bandinelli; Edgar R Miller; Carmelinda Ruggiero; Antonio Cherubini; Jack M Guralnik; Luigi Ferrucci
Journal:  Clin Chem       Date:  2008-01-17       Impact factor: 8.327

6.  Contrasting effects of n-3 and n-6 fatty acids on cyclooxygenase-2 in model systems for arthritis.

Authors:  Samantha Hurst; Sarah G Rees; Peter F Randerson; Bruce Caterson; John L Harwood
Journal:  Lipids       Date:  2009-09-26       Impact factor: 1.880

Review 7.  Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities.

Authors:  Petros Efthimiou; Manil Kukar
Journal:  Rheumatol Int       Date:  2009-10-30       Impact factor: 2.631

8.  DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men.

Authors:  Darshan S Kelley; David Siegel; Dawn M Fedor; Yuriko Adkins; Bruce E Mackey
Journal:  J Nutr       Date:  2009-01-21       Impact factor: 4.798

9.  Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.

Authors:  Signe Holm Nielsen; Samra Sardar; Anne Sofie Siebuhr; Annette Schlemmer; Erik Berg Schmidt; Anne-Christine Bay-Jensen; Morten A Karsdal; Jeppe Hagstrup Christensen; Salome Kristensen
Journal:  Rheumatol Int       Date:  2021-04-22       Impact factor: 2.631

10.  Incorporation of n-3 PUFA and γ-linolenic acid in blood lipids and red blood cell lipids together with their influence on disease activity in patients with chronic inflammatory arthritis--a randomized controlled human intervention trial.

Authors:  Christine Dawczynski; Ursula Hackermeier; Martin Viehweger; Rainer Stange; Monika Springer; Gerhard Jahreis
Journal:  Lipids Health Dis       Date:  2011-08-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.